Dobre, E.-G. (2025) “Investigating RUNX2 KO in B16 melanoma cells as a potential strategy to enhance in vivo tumor response to therapeutic approaches”, South East European Journal of Immunology, 8(CITIM), p. 065. doi: 10.3889/seejim.2025.6121.